Compound: drostanolone propionate
SMILES: O=C1[C@@H](C[C@@]2([C@@H]3[C@H]([C@H]4[C@]([C@@H](OC(=O)CC)CC4)(C)CC3)CC[C@H]2C1)C)C
InChIKey: NOTIQUSPUUHHEH-UXOVVSIBSA-N
Synonyms: drostanolone propionate, DROMOSTANOLONE PROPIONATE, 521-12-0, Permastril, Emdisterone, Masterid, Masteron, Drolban, Blackburn Compound, Masteril, Masterone, 2MDTP, 2M-DHTP, Medrotestrone propionate, Medrotestrone propanoate, NSC-1298, NSC-12198, 2alpha-Methyl-4,5-dihydrotestosterone propionate, 17beta-Hydroxy-2alpha-methyl-5alpha-androstan-3-one propionate, Testosterone, 4,5alpha-dihydro-2alpha-methyl-, propionate, X20UZ57G4O, 2alpha-methyl-3-oxo-5alpha-androstan-17beta-yl propanoate, [(2R,5S,8R,9S,10S,13S,14S,17S)-2,10,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] propanoate, CHEBI:31523, NSC12198, ((2R,5S,8R,9S,10S,13S,14S,17S)-2,10,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta(a)phenanthren-17-yl) propanoate, Compound 32379, RefChem:55072, NSC 12198, 2alpha-Methyldihydrotestosterone propionate, 2 Alpha-Methyldihydrotestosterone Propionate, 2-Alpha-Methyldihydrotestosterone Propionate, 208-303-1, Medrotestron propionate, MDHT, Lilly 32379, Re 346, Dromostanolone proprionate, RS 1567, 17b-hydroxy-2a-methyl-5a-androstan-3-one propionate, Dromostanolone propionate [USAN], MFCD01669961, 2.alpha.-Methyldihydrotestosterone propionate, 2.alpha.-Methyl-4,5-dihydrotestosterone propionate, Drostanolone propionate (JAN), Dromostanolone propionate (USAN), Nomasteron, 17.beta.-Hydroxy-2.alpha.-methyl-5.alpha.-androstan-3-one propionate, DROSTANOLONE PROPIONATE [JAN], Drolban (TN), Androstan-3-one, 2-methyl-17-(1-oxopropoxy)-, (2a,5a,17b)-, Drostanolone Propionate (1mg/ml in Acetonitrile), Dromostanolone 17-propionate, UNII-X20UZ57G4O, Masteron (TN), EINECS 208-303-1, Dromostanolone propionate [USAN:USP], BRN 3161958, AI3-52810, SCHEMBL3173, Androstan-3-one, 2-methyl-17-(1-oxopropoxy)-, 4-08-00-00654 (Beilstein Handbook Reference), GTPL6947, CHEMBL1201048, DTXSID1022972, Androstan-3-one, 2-methyl-17-(1-oxopropoxy)-, (2.alpha.,5.alpha.,17.beta.)-, s4794, DROMOSTANOLONE PROPIONATE [MI], AKOS015895157, CCG-268166, DB14655, DROSTANOLONE PROPIONATE [MART.], DS-3972, DROSTANOLONE PROPIONATE [WHO-DD], NCGC00507798-01, (2R,5S,8R,9S,10S,13S,14S,17S)-2,10,13-trimethyl-3-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl propionate, HY-107344, CS-0028187, NS00032424, C15917, D01534, DROMOSTANOLONE PROPIONATE [ORANGE BOOK], Drostanolone Propionate (1 mg/ml in Acetonitrile), Q5308606, W-105852, Drostanolone propionate 100 microg/mL in Acetonitrile, (2a,5a,17b)-2-Methyl-17-(1-oxopropoxy)androstan-3-one, Testosterone,5.alpha.-dihydro-2.alpha.-methyl-, propionate, 2a-Methyl-17b-hydroxy-5a -a  ndrostan-3-one 17-propionate, Testosterone, 4,5.alpha.-dihydro-2.alpha.-methyl-, propionate, (2alpha,5alpha,17beta)-2-methyl-3-oxoandrostan-17-yl propanoate, 5-alpha-Androstan-3-one, 17-beta-hydroxy-2-alpha-methyl-, propionate, 5.alpha.-Androstan-3-one, 17.beta.-hydroxy-2.alpha.-methyl-, propionate, Androstan-3-one, 2-methyl-17-(1-oxopropoxy)-, (2alpha,5alpha,17beta)-, 2-Methyl-3-oxoandrostan-17-yl propionate, (2.alpha.,5.alpha.,17.beta.)- #, ANDROSTAN-3-ONE, 2-METHYL-17-(1-OXOPROPOXY)-, (2.ALPHA.,5.ALPHA.,17.BETA
Theoretical properties:
molecular_formula: C23H36O3
molecular_weight: 360.5 g/mol
exact_mass: 360.26644501 g/mol
formal_charge: 0
hydrogen_bond_donor_count: 0
hydrogen_bond_acceptor_count: 3
rotatable_bond_count: 3
heavy_atom_count: 26
topological_polar_surface_area: 43.4 Å²
isotope_atom_count: 0
covalently_bonded_unit_count: 1
Physical properties:
Descriptions:
pubchem: Dromostanolone propionate is a 3-oxo-5alpha-steroid and a steroid ester. It has a role as an antineoplastic agent. It is functionally related to a metholone.
chembl: DROMOSTANOLONE PROPIONATE is a small molecule listed in the ChEMBL database and has reached clinical trial phase 4.0.
wikipedia: Drostanolone propionate, or dromostanolone propionate, sold under the brand names Drolban, Masteril, and Masteron among others, is an androgen and anabolic steroid (AAS) medication which was used to treat breast cancer in women but is now no longer marketed. It is given by injection into muscle.
Side effects of drostanolone propionate include symptoms of masculinization like acne, increased hair growth, voice changes, and increased sexual desire. It has no risk of liver damage. The drug is a synthetic androgen and anabolic steroid and hence is an agonist of the androgen receptor (AR), the biological target of androgens like testosterone and dihydrotestosterone (DHT). It has moderate anabolic effects and weak androgenic effects, which give it a mild side effect profile and make it especially suitable for use in women. The drug has no estrogenic effects. Drostanolone propionate is an androgen ester and a long-lasting prodrug of drostanolone in the body.
Drostanolone propionate was first described in 1959 and was introduced for medical use in 1961. In addition to its medical use, drostanolone propionate is used to improve physique and performance. The drug is a controlled substance in many countries and so non-medical use is generally illicit.